A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia

This study has been completed.
Information provided by (Responsible Party):
Sumitomo Dainippon Pharma Co., Ltd.
ClinicalTrials.gov Identifier:
First received: June 6, 2012
Last updated: June 30, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)